Beverly A. Teicher

Beverly A. Teicher, PhD, is a prominent cancer researcher best known for her pioneering work in solid tumor models, physiologic measurements of tumor hypoxia and oxygenation, and the study of anti-angiogenic agents.[1] She serves as part of the Coordinating Center for the Pediatric Preclinical In Vivo Testing Consortium (PIVOT) at The Jackson Laboratory, contributing to rigorous preclinical testing of novel molecularly targeted agents using in vivo models of pediatric cancer.[2] Her extensive publications include studies on high-dose chemotherapy regimens for advanced breast cancer.[3]